A bipartisan duo of lawmakers on the House Energy and Commerce Committee's health panel last week asked the National Institutes of Health to weigh in on medical issues related to last year's fungal meningitis outbreak, including the agency's role in finding treatments. The outbreak has stirred legislative action related to FDA oversight, but a researcher said medical issues -- including the adequacy of treatments and diagnostics used on infected patients -- has been absent from the debate.
576 words
pay to read found here
No comments:
Post a Comment